Constitutional methylation of the BRCA1 promoter in hereditary breast cancer patients lacking BRCA1 mutation

被引：0
|
作者：
White, KK
Booker, J
Silverman, LM
Coleman, WB
机构：
[1] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA
[2] Univ Virginia Hlth Syst, Mol Diagnost Lab, Charlottesville, VA USA
来源：
FASEB JOURNAL | 2004年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A186 / A186
页数：1
相关论文
共 50 条
  • [1] Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast Cancer
    Wong, Ee Ming
    Southey, Melissa C.
    Fox, Stephen B.
    Brown, Melissa A.
    Dowty, James G.
    Jenkins, Mark A.
    Giles, Graham G.
    Hopper, John L.
    Dobrovic, Alexander
    [J]. CANCER PREVENTION RESEARCH, 2011, 4 (01) : 23 - 33
  • [2] Methylation of BRCA1 promoter in sporadic breast cancer
    Jagtap, Sunil Vitthalrao
    Jagtap, Swati S.
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2023, 158 (01) : 85 - 87
  • [3] BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype
    Snell, Cameron
    Krypuy, Michael
    Wong, Ee Ming
    Loughrey, Maurice B.
    Dobrovic, Alexander
    [J]. BREAST CANCER RESEARCH, 2008, 10 (01):
  • [4] BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation
    Iwamoto, Takashi
    Yamamoto, Noriaki
    Taguchi, Tetsuya
    Tamaki, Yasuhiro
    Noguchi, Shinzaburo
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (01) : 69 - 77
  • [5] BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation
    Takashi Iwamoto
    Noriaki Yamamoto
    Tetsuya Taguchi
    Yasuhiro Tamaki
    Shinzaburo Noguchi
    [J]. Breast Cancer Research and Treatment, 2011, 129 : 69 - 77
  • [6] Immunolocalization of BRCA1 protein in tumor breast tissue: prescreening of BRCA1 mutation in Tunisian patients with hereditary breast cancer?
    Troudi, W.
    Uhrhammer, N.
    Ben Romdhane, K.
    Sibille, C.
    Mahfoudh, W.
    Chouchane, L.
    Ben Ayed, F.
    Bignon, Y. -J.
    Elgaaied, A. Ben Ammar
    [J]. EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2007, 51 (03): : 219 - 226
  • [7] Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens
    Rice, JC
    Ozcelik, H
    Maxeiner, P
    Andrulis, I
    Futscher, BW
    [J]. CARCINOGENESIS, 2000, 21 (09) : 1761 - 1765
  • [8] Mosaic BRCA1 promoter methylation contribution in hereditary breast/ovarian cancer pedigrees
    Schwartz, Mathias
    Ibadioune, Sabrina
    Chansavang, Albain
    Vacher, Sophie
    Caputo, Sandrine M.
    Delhomelle, Helene
    Wong, Jennifer
    Abidallah, Khadija
    Moncoutier, Virginie
    Becette, Veronique
    Popova, Tatiana
    Suybeng, Voreak
    De Pauw, Antoine
    Stern, Marc-Henri
    Colas, Chrystelle
    Mouret-Fourme, Emmanuelle
    Stoppa-Lyonnet, Dominique
    Golmard, Lisa
    Bieche, Ivan
    Masliah-Planchon, Julien
    [J]. JOURNAL OF MEDICAL GENETICS, 2024, 61 (03) : 284 - 288
  • [9] BRCA1 and BRCA2 in hereditary breast cancer
    Scully, R
    Puget, N
    [J]. BIOCHIMIE, 2002, 84 (01) : 95 - 102
  • [10] The BRCA1 promoter methylation is one of the mechanisms of th BRCA1 dysfunction of triple-negative breast cancer
    Yamashita, N.
    Tokunaga, E.
    Tanaka, K.
    Saeki, H.
    Oki, E.
    Kitao, H.
    Morita, M.
    Maehara, Y.
    [J]. CANCER RESEARCH, 2013, 73
12345